Schering Report issue

Contributed to NME For profit Phase 2
Founded: Berlin Germany (1851)
Status: Acquired by Schering-Plough (1971) → now Merck (2009)

Organization Overview

First Clinical Trial
2003
NCT00162851
First Marketed Drug
1943
ethinyl estradiol (Estinyl)
First NDA Approval
1960
trichlormethiazide (naqua)
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

SCHERING | Schering Corporation | Schering Nordiska AB